OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
Vivek P. Chavda, Disha Valu, Palak K. Parikh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 374-374
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Lalitkumar K. Vora, Amol D. Gholap, Keshava Jetha, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1916-1916
Open Access | Times Cited: 393

Unveiling the promise: Exosomes as game‐changers in anti‐infective therapy
Vivek P. Chavda, Guanghong Luo, Rajashri Bezbaruah, et al.
Exploration (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 23

Rapid, multiplexed, and enzyme-free nucleic acid detection using programmable aptamer-based RNA switches
Zhaoqing Yan, Amit Eshed, Anli A. Tang, et al.
Chem (2024) Vol. 10, Iss. 7, pp. 2220-2244
Closed Access | Times Cited: 7

Exosomes in transplantation: Role in allograft rejection, diagnostic biomarker, and therapeutic potential
Prathab Balaji Saravanan, Jagan Kalivarathan, Faizaan Khan, et al.
Life Sciences (2023) Vol. 324, pp. 121722-121722
Closed Access | Times Cited: 15

A review of current effective COVID-19 testing methods and quality control
Lijia Cheng, Liang Lan, Murugan Ramalingam, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 6
Open Access | Times Cited: 15

Regulatory processes involved in clinical trials and intellectual property rights around vaccine development
Nimeet Desai, Shreya Pande, Amol D. Gholap, et al.
Elsevier eBooks (2024), pp. 279-309
Closed Access | Times Cited: 4

COVID-19: India’s Economic Crunch and Proposed Advanced Technological Measures to Restrain Future Infections
Vineeta Singh, Shashi Prakash Gupta, Sujoy Kumar Samanta
Reviews of Environmental Contamination and Toxicology (2025) Vol. 263, Iss. 1
Closed Access

Development of a nucleic acid-based screen printed electrochemical biosensor using Ti3C2Tx-MXene for the detection of SARS-CoV-2
Anu Bharti, Sonam Singh, Dhanunjaya Munthala, et al.
Microchemical Journal (2023) Vol. 195, pp. 109521-109521
Closed Access | Times Cited: 10

Artificial Intelligence in Pharmaceutical Drug Delivery
Gaurav Agrawal, Shiva Tushir, Shiva Tushir, et al.
(2024), pp. 406-410
Closed Access | Times Cited: 3

SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3

History of vaccination
Vivek P. Chavda, Pankti C. Balar, Vasso Apostolopoulos
Elsevier eBooks (2024), pp. 1-12
Closed Access | Times Cited: 1

Applications of Artificial Intelligence in Pharmaceutical Research: An Extensive Review
G Nihalani
Bioequivalence & Bioavailability International Journal (2024) Vol. 8, Iss. 1, pp. 1-7
Open Access | Times Cited: 1

Comparative Analysis of QCM and Electrochemical Aptasensors for SARS-CoV-2 Detection
Katarína Nemčeková, Jana Korčeková, Veronika Svitková, et al.
Biosensors (2024) Vol. 14, Iss. 9, pp. 431-431
Open Access | Times Cited: 1

The potential of circulating microRNAs as novel diagnostic biomarkers of COVID-19: a systematic review and meta-analysis
Melaku Ashagrie Belete, Denekew Tenaw Anley, Sintayehu Simie Tsega, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Advancing SARS‐CoV‐2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure
Jea Sung Ryu, Soo Hyun Lee, Hye-Ran Kim, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 1

Oral Vaccine Delivery
Pankti C. Balar, Vidhi A. Modh, Sanjay P. Chauhan, et al.
(2024), pp. 345-366
Closed Access

Parenteral vaccine delivery
Keshava Jetha, Niva Rani Gogoi, Anup Kumar, et al.
Elsevier eBooks (2024), pp. 167-205
Closed Access

Automation Techniques in Clinical Virology
Shreya Yadav, Meraj A. Khan, Jyoti Bala
(2024), pp. 101-118
Closed Access

The Use of Nanomaterials in Activating the Complement System
Vivek P. Chavda, Amol D. Gholap, Rajashri Bezbaruah, et al.
(2024), pp. 85-103
Closed Access

Nanotechnology and Vaccine Development
Keshava Jetha, Praful D. Bharadia, Manish P. Patel
(2024), pp. 63-93
Closed Access

Mass Spectrometry-Based Metabolomics Reveals a Salivary Signature for Low-Severity COVID-19
Iasmim Lopes de Lima, Alex Silva, Carlos Brites, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11899-11899
Open Access

Innovative Strategies for Enhancing AuNP-Based Point-of-Care Diagnostics: Focus on Coronavirus Detection
Zhenquan Lai, Fangxin Wang, Yishuang Cui, et al.
Talanta (2024) Vol. 285, pp. 127362-127362
Closed Access

Coronaviruses: Pandemic SARS-CoV-2
Benjamin J. Cowling, Sook‐San Wong
Springer eBooks (2024), pp. 1-79
Closed Access

Page 1 - Next Page

Scroll to top